Wednesday, December 17, 2025 12/17/2025

Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters

Award Number: K23HL146942
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 04/01/2020
PERIOD OF PERFORMANCE END DATE: 03/31/2025

Group Awards By:

View Award Description

Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters - PROJECT SUMMARY/ABSTRACT Pulmonary fibrosis (PF) is a destructive interstitial lung disease (ILD) characterized by profound scarring. In severe PF, death generally ensues within 3-5 years. While current classification criteria guide diagnosis, prognosis and treatment of PF, substantial heterogeneity in PF phenotypes limit the utility of these criteria. Many patients classified as idiopathic PF may belong to alternative PF subclasses, and a significant minority of patients are unclassifiable. Recent genomic advances have identified factors that influence heterogeneity in PF however, exclusion of major racial groups from these genetic studies limits the generalizability of their findings. In this proposal, I aim to improve disease classification and outcome prediction in patients with PF. I will do this using cutting-edge statistical tools and DNA samples collected from patients across diverse races. My central hypothesis is that inclusion of genomic biomarkers from diverse races into a cluster-based model will lead to better PF classification. I will first perform targeted genotyping for PF-associated gene variants and measure telomere lengths to determine their variation across US racial groups with PF. I will then derive and validate a PF cluster model using clinical data from racially diverse PF populations and determine the additional value of genomic data on outcome prediction. Finally, using this model, I will determine heterogeneity of treatment effect on outcomes across patients prospectively enrolled in national PF registries. Successful completion of this proposal will result in a validated Clusters Across Subgroups of Pulmonary Fibrosis (CLASS-PF) model applicable in patients from diverse races to improve PF classification and outcome prediction. My preliminary studies in clinical prediction modeling, and completion of a Master’s Degree in Public Health Sciences have provided a solid foundation for success in this investigation. My long-term career goal is to utilize genetic data from diverse races to improve clinical decision-making and outcomes for patients with PF. To achieve this, I have formulated a career development plan that will provide exceptional mentorship, and training in genomic analyses, statistical genetics, big-data analysis and clinical trials. Leading experts in ILD, genetics, and risk-stratification modeling will mentor me. I have also assembled a multidisciplinary advisory committee with expertise in telomere disorders, clinical trials, and biorepository processing. The outlined work will be performed at the University of Chicago, an institution with established track record of excellence in patient-oriented research, and abundant resources for collaboration. This K23 award is fundamental to achieve successfully the goals outlined in this proposal, as it will provide dedicated time to attain these realistic milestones and acquire the skills to independently develop genomic prediction tools that integrate clinical phenotype data for subsequent validation in clinical trials. This work will provide an invaluable pharmacogenomic resource for studying PF across diverse races, and improve PF classification and prediction thus channeling discovery into translation and ultimately to clinical implementation.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = -$11,540 )
2026	2024	UNIVERSITY OF CHICAGO	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Lung Diseases Research	000	5	12/3/2025	NON-COMPETING CONTINUATION	-$11,540
														Subtotal = -$11,540

Issue Date FY: 2024 ( Subtotal = $162,432 )
2024	2024	UNIVERSITY OF CHICAGO	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Lung Diseases Research	000	5	4/4/2024	NON-COMPETING CONTINUATION	$162,432
														Subtotal = $162,432

Issue Date FY: 2023 ( Subtotal = $162,432 )
2023	2023	UNIVERSITY OF CHICAGO	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Lung Diseases Research	000	4	3/31/2023	NON-COMPETING CONTINUATION	$162,432
														Subtotal = $162,432

Issue Date FY: 2022 ( Subtotal = $162,432 )
2022	2022	UNIVERSITY OF CHICAGO, THE	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Lung Diseases Research	000	3	3/1/2022	NON-COMPETING CONTINUATION	$162,432
														Subtotal = $162,432

Issue Date FY: 2021 ( Subtotal = $161,152 )
2021	2021	UNIVERSITY OF CHICAGO, THE	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Lung Diseases Research	000	2	3/26/2021	NON-COMPETING CONTINUATION	$161,152
														Subtotal = $161,152

Issue Date FY: 2020 ( Subtotal = $161,152 )
2020	2020	UNIVERSITY OF CHICAGO, THE	5801 S ELLIS AVE	CHICAGO	IL	60637	COOK	USA	Lung Diseases Research	000	1	3/27/2020	NEW	$161,152
														Subtotal = $161,152

Grand Total All Awards = $798,060

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Improving Pulmonary Fibrosis Classification with Genomics Informed Phenotypic Clusters

Award Number: K23HL146942

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 04/01/2020

PERIOD OF PERFORMANCE END DATE: 03/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer